InMed Pharmaceuticals Inc. (NASDAQ: INM) closed its private placement with two healthcare-focused institutional investors for the issuance and sale of 1.8 million of its common shares at a purchase price of $3.30 per share priced at-the-market under Nasdaq rules. In addition, the company has issued to the investors in the offering unregistered preferred investment options to purchase up to an aggregate of 3.3 million common shares. The aggregate gross …

Full story available on Benzinga.com